Acta chirurgica Iugoslavica 2007 Volume 54, Issue 1, Pages: 177-195
doi:10.2298/ACI0701177V
Full text ( 220 KB)
Cited by


Systemic hemostatic drugs

Vučelić D., Peško P., Stojakov D., Sabljak P., Bjelović M., Dunjić M., Ebrahimi K., Nenadić B., Veličković D., Špica B.

Understanding the haemostatic changes is crucial in developing strategies for the management of haemorrhage syndroma. In recent years, the revised model of coagulation ("cell based" model) provided a much more authentic description of the coagulation process. Pharmacological intervention, especially desmopresin, antifibrinolytics (synthetics and nature) and increasingly recombinant activated factor VII are being used in prevention and therapeutically to control bleeding of variety etiologies. Skilful surgery combined with blood saving methods and careful management of blood coagulation will all help in successful hemorrhage prevention and treatment, and reduce unnecessary blood loss and transfusion requirements and its attendant risks. Among the all avalaible tests, the use of thromboelastography has allowed for more detailed dynamic assessment of the various steps of hemostasis.

Keywords: hemostasis, bleeding, hemostatic drugs

More data about this article available through SCIndeks